Development, characterization and cancer targeting potential of surface engineered carbon nanotubes

Journal of Drug Targeting

Volumn 21, Issue 8, 2013, Pages 745-758

  Mehra, Neelesh Kumar ^a   Jain, N K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Anti tumor activity; Carbon nanotubes; Doxorubicin; Drug targeting; Folic acid; MCF 7 cells; Pharmacokinetic

Indexed keywords

DOXORUBICIN; DOXORUBICIN FOLIC ACID MACROGOL 4000 MULTI WALLED CARBON NANOTUBE; DOXORUBICIN FOLIC ACID MULTI WALLED CARBON NANOTUBE; FOLIC ACID; MACROGOL 4000; MULTI WALLED NANOTUBE; NANOCONJUGATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL STRAIN MCF 7; CHEMICAL INTERACTION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; ENDOCYTOSIS; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NANOENGINEERING; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; FEMALE; FOLIC ACID; HUMANS; HYDROGEN-ION CONCENTRATION; MCF-7 CELLS; NANOTUBES, CARBON; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 84883245595     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.813028     Document Type: Article

References (46)

1. Gupta U, Dwivedi SKD, Bid HK, et al. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int J Pharm 2010;393: 185-96.
2. Jain NK, Mishra V, Mehra NK. Targeted drug delivery to macrophages. Exp Opinion Drug Deliv 2013;10: 353-67.
3. Bianco A, Kostarelos K, Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem Commun 2011;47: 10182-8.
4. Mehra NK, Jain AK, Lodhi N, et al. Challenges in the use of carbon nanotubes in biomedical applications. Crit Rev Ther Drug Carr Syst 2008;25: 169-206. (Pubitemid 351655040)
5. Mehra NK, Mishra V, Jain NK. A review on receptor based therapeutic targeting. Ther Deliv 2013;4: 369-94.
6. Singh R, Mehra NK, Jain V, Jain NK. Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cell. J Drug Target 2013. [Epub ahead of print]. doi: 10.3109/ 1061186X.2013.778264.
7. Mehra NK, Sharma S, Singhai AK, Kumar V. Carbon nanotubes: a new line to drug delivery. Pharm Rev 2011;9: 75-80.
8. Gu YJ, Cheng J, Jin J, et al. Development and evaluation of pHresponsive single-walled carbon nanotube-doxorubicin complexes in cancer cells. Int J Nanomed 2011;6: 2889-98.
9. Liu Z, Sun X, Nakayama-Ratchford N, Dai H. Supramolecular chemistry on water soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007;11: 50-6.
10. Pantarotto D, Hoebeke J, Graff R. Synthesis, structural characterization and immunological properties of carbon nanotubes functionalized with peptides. J Am Chem Soc 2003;125: 6160-4. (Pubitemid 36582988)
11. Villa CH, Dao T, Ahearn I, et al. Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens. ACS Nano 2011;5: 5300-12.
12. Wang L, Zhang WL, Zhang M, et al. Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by singe-walled carbon nanotubes. Int J Nanomed 2011;6: 2641-52.
13. Jain AK, Dubey V, Mehra NK, et al. Carbohydrate conjugated multi walled carbon nanotubes: Development and characterization. Nanomed: Nanotech Biol Med 2009;5: 432-42.
14. Varkouhi K, Foillard S, Lammers T, et al. SiRNA delivery with functionalized carbon nanotubes. Int J Pharm 2011;416: 419-25.
15. Lodhi N, Mehra NK, Jain NK. Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes. J Drug Target 2013;21: 67-76.
16. Pruthi J, Mehra NK, Jain NK. Macrophages targeting of amphotericin B through mannosylated multi walled carbon nanotubes. J Drug Target 2012;20: 593-604.
17. Shvedova AA, Tkach AV, Kisin ER, et al. Carbon nanotubes enhance metastatic growth of lung carcinoma via up-regulation of myeloid-derived suppressor cells. Small 2013;9: 1691-5.
18. Simenova PP. Update on carbon nanotubes toxicity. Fut Nanomed 2009;4: 373-75.
19. Agrawal A, Gupta U, Asthana A, Jain NK. Dextran conjugated dendrite nanoconstructs as potential vectors for anti-cancer agent. Biomaterials 2009;30: 3588-96.
20. Meng L, Zhang X, Lu Q, et al. Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors. Biomaterials 2012;33: 1689-98.
21. Kaminskas LM, McLeod VM, Kelly BD, et al. A comparison of changes to doxorubicin pharmacokinetics, antitumor activity and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. Nanomed: Nanotech Biol Med 2011;8: 103-11.
22. Huang H, Yuan Q, Shah JS, Misra RDK. A new family of folatedecorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery response. Adv Drug Deliv Rev 2011; 63: 1332-9.
23. Zhang X, Meng L, Lu Q, et al. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials 2009;30: 6041-7.
24. Singh P, Gupta U, Asthana A, Jain NK. Folate and folate-PEGPAMAM dendrimer: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconj Chem 2008;19: 2239-52.
25. Datsyuk V, Kalyva M, Papagelis K, et al. Chemical oxidation of multi walled carbon nanotubes. Carbon 2008;46: 833-40.
26. Boehm HP. Surface oxides on carbon and their analysis: a critical assessment. Carbon 2012;40: 145-9.
27. Yudianti R, Onggo H, Sudiraman Y, et al. Analysis of functional group sited on multi-wall carbon nanotubes. The Open Mat Sc 2011;5: 242-7.
28. Lee RJ, Low PS. Folate-mediated tumor cell targeting of liposomeentrapped doxorubicin in vitro. Biochim Biophys Acta 1995;1233: 134-44.
29. Shi X, Wang SH, Shen M, et al. Multifunctional dendrimermodified multiwalled carbon nanotubes: synthesis, characterization and in vitro cancer cell targeting and imaging. Biomacromolecules 2009;10: 1744-50.
30. Mishra V, Gupta U, Jain NK. Influence of different generations of poly (propylene imine) dendrimers on human erythrocytes. Pharmazie 2010;65: 891-5.
31. Prickett WM, Rite BDV, Resasco DE, Harrison RG. Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer. Nanotechnology 2011;22:455101: 1-7.
32. Ji Z, Lin G, Lu Q, et al. Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. J Colloid Interface Sci 2012; 365: 143-9.
33. Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008;68: 6652-60.
34. Bhirde AA, Patel V, Gavard J, et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotubes-based drug delivery. ACS Nano 2009;3: 307-16.
35. Reddy LH, Murthy RSR. Pharmacokinetics and biodistribution studies of doxorubicin loaded poly (butylcyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Pap 2004; 148: 161-6.
36. Sachar S, Saxena RK. Cytotoxic effect of poly-dispersed single walled carbon nanotubes on erythrocytes in vitro and in vivo. PLoS ONE 2011;6:e22032(1-8).
37. Lu YJ, Wei KC, Ma CCM, et al. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Colloids Surfaces B: Biointerfaces 2012;89: 1-9.
38. Liu Z, Davis C, Cai W, et al. Circulation and long-term fate of functionalized biocompatible single-walled carbon nanotubes in mice probed by raman spectroscopy. Proc Nat Acad Sci USA 2008;105: 1410-15. (Pubitemid 351346531)
39. Cherukari P, Gannon CJ, Leeuw TK, et al. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Nat Acad Sci USA 2006;103: 18882-6. (Pubitemid 350002796)
40. Chen J, Chen S, Zhao X, et al. Functionalized single-walled carbon nanotubes as rationally designed vehicle for tumor-targeted drug delivery. J Am Chem Soc 2008;130: 16778-85.
41. Liu Z, Cai W, He L, et al. In-vivo biodistribution and highly efficient tumor targeting of carbon nanotubes in mice. Nat Nanotech 2007;2: 47-52. (Pubitemid 46210038)
42. Ren J, Shen S, Wang D, et al. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidised multi-walled carbon nanotubes modified with angiopep-2. Biomaterials 2012;33: 3324-33.
43. Shen S, Ren J, Chen J, et al. Development of magnetic multi walled carbon nanotubes combined with near-infrared radiation-assisted desorption for the determination of tissue distribution of doxorubicin liposome injects in rats. J Chromatography A 2011;1218: 4619-26.
44. Prabharan M, Grailer JJ, Pilla S, et al. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn- H40, poly (L-lactide) and poly (ethylene glycol) for tumor-targeted drug delivery. Biomaterials 2009;30: 3009-19.
45. Park J, Fong PM, Lu J, et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomed: Nanotech Biol Med 2009;5: 410-18.
46. Rose PG. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer. Oncologist 2005;10: 205-14. (Pubitemid 40463158)